Tarja Heiskanen-Kosma
Tarja Heiskanen-Kosma has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Quiambao
Research Institute for Tropical Medicine, Metro Manila, The Philippines
1 shared publication - Eric A. F. Simoes
Department of Pediatrics, The University of Colorado School of Medicine and The Children's Hospital, Denver, USA
1 shared publication - Erma Abucejo-Ladesma
Research Institute for Tropical Medicine, Metro Manila, The Philippines
1 shared publication - Hanna Nohynek
National Public Health Institute (KTL), Helsinki, Finland
1 shared publication - Ian Riley
University of Queensland, Brisbane, Australia
1 shared publication - Marilla G. Lucero
Research Institute for Tropical Medicine, Muntinlupa City, Philippines
1 shared publication
Latest Publications
- Open Access
- 21 July 2008
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 95
Clinical case review: A method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia
The World Health Organization's (WHO) case definition for childhood pneumonia, composed of simple clinical signs of cough, difficult breathing and fast breathing, is widely used in resource poor settings to guide management of acute respiratory infections. The definition is also commonly used as an entry criteria or endpoint in different intervention and disease burden studies.
- 21 July 2008
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 95
Open AccessClinical case review: A method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia
The World Health Organization's (WHO) case definition for childhood pneumonia, composed of simple clinical signs of cough, difficult breathing and fast breathing, is widely used in resource poor settings to guide management of acute respiratory infections. The definition is also commonly used as an entry criteria or endpoint in different intervention and disease burden studies.